• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎所致肝硬化与隐源性肝硬化的三相CT扫描结果评估

Assessment of Three-Phasic CT Scan Findings of Cirrhosis Due to Primary Sclerosing Cholangitis Versus Cryptogenic Cirrhosis.

作者信息

Sadraei Nazanin, Jafari Hamed, Sadraee Amin, Zeinali-Rafsanjani Banafsheh, Rastgooyan Hemmatollah, Zahergivar Aryan

机构信息

Department of Radiology, Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, IRN.

Department of Urology, Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, IRN.

出版信息

Cureus. 2022 Apr 8;14(4):e23956. doi: 10.7759/cureus.23956. eCollection 2022 Apr.

DOI:10.7759/cureus.23956
PMID:35547407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9085709/
Abstract

BACKGROUND

The CT findings of cirrhosis caused by primary sclerosing cholangitis (PSC) differ from cryptogenic cirrhosis. PSC could become complicated with biliary cirrhosis and cholangiocarcinoma. This study aimed at augmenting the information on the role of the three-phasic-abdominopelvic CT scan in PSC.

MATERIAL AND METHODS

A total of 185 CT scans were retrospectively reviewed, including 100 patients with cryptogenic cirrhosis and 85 patients with PSC-cirrhosis. Different morphologic criteria were compared, including segmental atrophy/hypertrophy, hepatic contour, portal-hypertension, perihilar lymphadenopathy, biliary tree dilatation, gallbladder appearance. Inflammatory-bowel-disease (IBD) and cholangiocarcinoma frequency, presence of perihilar lymph nodes (LNs), and their size during end-stage PSC cirrhosis are investigated.

RESULTS

Six findings occur more frequently with PSC than those diagnosed with cryptogenic cirrhosis. Modified caudate/right lobe (m-CRL) ratio >0.73, moderate and severe lobulated liver contour, lateral left lobe atrophy, over distended gallbladder (GB), biliary tree dilatation and wall thickening, and LN sizes were higher in PSC patients as compared to cryptogenic cirrhosis (P < 0.005). Ascites and portosystemic collateral formations were significant in cryptogenic cirrhosis compared to PSC patients (P < 0.005). Cholangiocarcinoma frequency in PSC patients was 14.7%, and the frequency of inflammatory bowel disease (IBD) was 57.6%. Further, 22.4% of the patients were diagnosed with IBD and PSC simultaneously. The LN number and size in PSC patients were not different between those with or without cholangiocarcinoma.

CONCLUSION

Using three-phasic CT scans and PSC characteristics could be considered as an additional suggestion besides pathology measures. Diagnosis of PSC based on histological findings could be a last resort due to its invasive essence and specific characteristics of PSC in imaging.

摘要

背景

原发性硬化性胆管炎(PSC)所致肝硬化的CT表现与隐源性肝硬化不同。PSC可并发胆汁性肝硬化和胆管癌。本研究旨在增加有关三相腹部盆腔CT扫描在PSC中作用的信息。

材料与方法

回顾性分析185例CT扫描,包括100例隐源性肝硬化患者和85例PSC肝硬化患者。比较不同的形态学标准,包括节段性萎缩/肥大、肝脏轮廓、门静脉高压、肝门周围淋巴结病、胆管树扩张、胆囊外观。研究终末期PSC肝硬化时炎症性肠病(IBD)和胆管癌的发生率、肝门周围淋巴结(LN)的存在情况及其大小。

结果

与诊断为隐源性肝硬化的患者相比,PSC患者出现六种表现的频率更高。与隐源性肝硬化相比,PSC患者的改良尾状叶/右叶(m-CRL)比值>0.73、中度和重度分叶状肝脏轮廓、左外侧叶萎缩、胆囊过度扩张(GB)、胆管树扩张和壁增厚以及LN大小更高(P<0.005)。与PSC患者相比,隐源性肝硬化患者的腹水和门体侧支循环形成更为显著(P<0.005)。PSC患者胆管癌的发生率为14.7%,炎症性肠病(IBD)的发生率为57.6%。此外,22.4%的患者同时被诊断为IBD和PSC。PSC患者中有无胆管癌的LN数量和大小无差异。

结论

除病理检查外,使用三相CT扫描和PSC特征可作为额外的诊断依据。基于组织学结果诊断PSC可能是最后的手段,因为其具有侵入性本质以及PSC在影像学上的特殊特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/dacfc8d10358/cureus-0014-00000023956-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/9177ecc9ccee/cureus-0014-00000023956-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/8c87f873f692/cureus-0014-00000023956-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/9ed5871051ab/cureus-0014-00000023956-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/8480dab8927f/cureus-0014-00000023956-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/dacfc8d10358/cureus-0014-00000023956-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/9177ecc9ccee/cureus-0014-00000023956-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/8c87f873f692/cureus-0014-00000023956-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/9ed5871051ab/cureus-0014-00000023956-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/8480dab8927f/cureus-0014-00000023956-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6538/9085709/dacfc8d10358/cureus-0014-00000023956-i05.jpg

相似文献

1
Assessment of Three-Phasic CT Scan Findings of Cirrhosis Due to Primary Sclerosing Cholangitis Versus Cryptogenic Cirrhosis.原发性硬化性胆管炎所致肝硬化与隐源性肝硬化的三相CT扫描结果评估
Cureus. 2022 Apr 8;14(4):e23956. doi: 10.7759/cureus.23956. eCollection 2022 Apr.
2
End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients.终末期原发性硬化性胆管炎:36例患者肝脏形态的CT表现
Radiology. 1999 May;211(2):357-62. doi: 10.1148/radiology.211.2.r99ma49357.
3
Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma.原发性硬化性胆管炎伴或不伴胆管细胞癌患者的肝门周围淋巴结
Scand J Gastroenterol. 2008;43(11):1366-70. doi: 10.1080/00365520802200002.
4
The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival.原发性硬化性胆管炎或炎症性肠病对胆管癌表型、治疗及生存的影响。
JGH Open. 2020 Aug 11;4(6):1128-1134. doi: 10.1002/jgh3.12405. eCollection 2020 Dec.
5
What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?在土耳其患者中,原发性硬化性胆管炎与性别及炎症性肠病之间有何关联?
Hepatogastroenterology. 1998 Nov-Dec;45(24):2064-72.
6
Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.炎症性肠病患者中,原发性硬化性胆管炎会增加肝胰胆管癌的风险:一项基于人群的队列研究。
United European Gastroenterol J. 2022 Mar;10(2):212-224. doi: 10.1002/ueg2.12204. Epub 2022 Feb 2.
7
Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.原发性硬化性胆管炎终末期伴或不伴胆管癌的癌前胆管病变。
Am J Surg Pathol. 2010 Jan;34(1):27-34. doi: 10.1097/PAS.0b013e3181bc96f9.
8
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
9
[Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].[摘自2022年美国肝病研究协会临床实践指南:原发性硬化性胆管炎和胆管癌的管理]
Zhonghua Gan Zang Bing Za Zhi. 2023 Jan 20;31(1):35-41. doi: 10.3760/cma.j.cn501113-20221226-00612.
10
Hepatobiliary complications of inflammatory bowel disease.炎症性肠病的肝胆并发症
Curr Gastroenterol Rep. 2011 Oct;13(5):495-505. doi: 10.1007/s11894-011-0213-9.

本文引用的文献

1
Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients.在伊朗患者中,肝硬化的病因正从乙型肝炎病毒转变为脂肪肝。
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S20-S26.
2
Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.炎症性肠病的病程与原发性硬化性胆管炎合并炎症性肠病患者胆管癌风险增加相关。
Am J Gastroenterol. 2016 May;111(5):705-11. doi: 10.1038/ajg.2016.55. Epub 2016 Mar 22.
3
The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures.
用于无创检测肝硬化的肝段体积比:与既定线性和体积测量方法的比较
J Comput Assist Tomogr. 2016 May-Jun;40(3):478-84. doi: 10.1097/RCT.0000000000000389.
4
Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.硬化性胆管炎:临床病理特征、影像学表现及鉴别诊断的系统方法
Korean J Radiol. 2016 Jan-Feb;17(1):25-38. doi: 10.3348/kjr.2016.17.1.25. Epub 2016 Jan 6.
5
The Gut-Liver Axis in Primary Sclerosing Cholangitis.原发性硬化性胆管炎的肠-肝轴。
Clin Liver Dis. 2016 Feb;20(1):1-14. doi: 10.1016/j.cld.2015.08.012. Epub 2015 Sep 26.
6
Liver cirrhosis.肝硬化。
Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.
7
Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression.原发性硬化性胆管炎的放射学病程:三维磁共振胆胰管成像评估及进展的预测特征。
Hepatology. 2014 Jan;59(1):242-50. doi: 10.1002/hep.26620. Epub 2013 Nov 22.
8
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.原发性硬化性胆管炎的发病机制及诊治进展。
Gastroenterology. 2013 Sep;145(3):521-36. doi: 10.1053/j.gastro.2013.06.052. Epub 2013 Jul 1.
9
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.原发性硬化性胆管炎和原发性胆汁性肝硬化的流行病学:系统评价。
J Hepatol. 2012 May;56(5):1181-1188. doi: 10.1016/j.jhep.2011.10.025. Epub 2012 Jan 13.
10
Primary sclerosing cholangitis: diagnostic and therapeutic problems.原发性硬化性胆管炎:诊断和治疗问题。
Dig Dis. 2011;29 Suppl 1:41-5. doi: 10.1159/000331074. Epub 2011 Nov 15.